Mr. Paul Duffy reports

AI/ML INNOVATIONS INC. CLOSES FIRST TRANCHE OF PRIVATE PLACEMENT

AI-ML Innovations Inc. has closed the first tranche of its previously announced non-brokered private placement pursuant to which the company has issued an aggregate of 16,385,000 units at a price of five cents per unit to raise aggregate gross proceeds of $819,250. Each unit is composed of one common share of the company and one common share purchase warrant. Subject to the anti-dilution provisions that are contained in the certificates governing the terms of the warrants, each whole warrant is exercisable to acquire one common share at a price of 15 cents for a period of 60 months from the date of issuance of the warrants.

In connection with the first tranche of the offering, the company also issued an aggregate of 936,950 broker warrants to eligible finders assisting in the offering, with each broker warrant entitling the holder to acquire one common share at an exercise price of 15 cents for a period of five years.

All securities issued and issuable in connection with the first tranche of the offering are subject to a statutory hold period expiring on Dec. 27, 2026.

About AI-ML Innovations Inc.

AI-ML Innovations is a global technology company pioneering the use of artificial intelligence and neural networks to transform digital health. Its proprietary platforms leverage advanced signal processing and deep learning to convert complex biometric data into actionable clinical insights -- supporting earlier diagnosis, personalized treatment and more effective care. AI-ML's shares trade on the Canadian Securities Exchange, the OTCQB Venture Market and the Frankfurt Stock Exchange.

We seek Safe Harbor.